CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-04 | RYAN ARTHUR F Director | Gift | −2,500 | 19,682 | ||
| 2022-08-04 | RYAN ARTHUR F Director | Option exercise | +3,613 | $482.68 | $1.7M | 23,295 |
| 2022-08-04 | RYAN ARTHUR F Director | Sale | −4,887 | $620.85 | $3.0M | 18,408 |
| 2022-08-04 | RYAN ARTHUR F Director | Option exercise | +4,361 | $374.12 | $1.6M | 22,769 |
| 2022-08-04 | RYAN ARTHUR F Director | Sale | −4,156 | $621.54 | $2.6M | 18,613 |
| 2022-08-04 | RYAN ARTHUR F Director | Option exercise | +2,479 | $380.95 | $944K | 21,092 |
| 2022-08-04 | RYAN ARTHUR F Director | Sale | −1,410 | $622.06 | $877K | 19,682 |
| 2022-08-04 | RYAN ARTHUR F Director | Option exercise · Non-Qualified Stock Option (right to buy) | −4,361 | 0 | ||
| 2022-08-04 | RYAN ARTHUR F Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,479 | 0 | ||
| 2022-08-04 | RYAN ARTHUR F Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,613 | 0 | ||
| 2022-08-04 | STAHL NEIL EVP Research and Development | Option exercise | +95,000 | $270.43 | $25.7M | 147,795 |
| 2022-08-04 | STAHL NEIL EVP Research and Development | Shares withheld for taxes | −71,218 | $613.00 | $43.7M | 76,577 |
| 2022-08-04 | STAHL NEIL EVP Research and Development | Option exercise · Non-Qualified Stock Option (right to buy) | −95,000 | 0 | ||
| 2022-07-05 | VAGELOS P ROY Director | Gift | −357 | 126,347 | ||
| 2022-05-24 | VAGELOS P ROY Director | Gift | −23,077 | 322,489 | ||
| 2022-04-06 | VAGELOS P ROY Director | Gift | −302 | 126,704 | ||
| 2022-02-18 | STAHL NEIL EVP Research and Development | Gift | −335 | 52,795 | ||
| 2020-06-09 | Sanofi 10% owner | Sale | −120,234 | $597.48 | $71.8M | 279,766 |
| 2020-05-29 | Sanofi 10% owner | Sale | −20,421,899 | $509.85 | $10.4B | 0 |
| 2020-05-29 | Sanofi 10% owner | Sale | −2,399,552 | $509.85 | $1.2B | 400,000 |
Page 77 of 105 · 2,088 trades